BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18561862)

  • 1. [Abatacept].
    Taéron C
    Rev Infirm; 2008 May; (140):47-9. PubMed ID: 18561862
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving patient outlook in rheumatoid arthritis: experience with abatacept.
    Coughlin M
    J Am Acad Nurse Pract; 2008 Oct; 20(10):486-95. PubMed ID: 19128344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
    Furfaro N
    Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746
    [No Abstract]   [Full Text] [Related]  

  • 4. [The distribution of drugs].
    Hallouet P; Eggers J; Malaquin-Pavan E
    Soins Gerontol; 2008; (69):43-4. PubMed ID: 18426053
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral chemotherapy medications: the need for a nurse's touch.
    Winkeljohn DL
    Clin J Oncol Nurs; 2007 Dec; 11(6):793-6. PubMed ID: 18063536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
    Scheinfeld N
    J Dermatolog Treat; 2006; 17(4):229-34. PubMed ID: 16971318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-lymphocyte antigen 4-immunoglobulin in rheumatoid arthritis.
    Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):381-91, viii. PubMed ID: 15172047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
    Konsta M; Rallis E; Karameris A; Stratigos A; Sfikakis PP; Iliopoulos A
    J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):257-8. PubMed ID: 22280512
    [No Abstract]   [Full Text] [Related]  

  • 9. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
    Sherrer Y
    Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duloxetine].
    Taéron C
    Rev Infirm; 2010; (162):41-3. PubMed ID: 20701239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sub-cutaneous injections].
    Soins Gerontol; 2007; (65):45-6. PubMed ID: 17583291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enoxaparine].
    Taéron C
    Rev Infirm; 2007 Mar; (128):41-2. PubMed ID: 17438935
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ribavirin].
    Taéron C
    Rev Infirm; 2009; (152):47-9. PubMed ID: 19702029
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drugs uses and effects. Corticosteroids.
    Jordan S; Griffiths H
    Nurs Stand; 2004 Mar 17-23; 18(27):2p.. PubMed ID: 15061025
    [No Abstract]   [Full Text] [Related]  

  • 15. Procainamide: Test your drug IQ.
    Gever MP
    Nursing; 2006; 36(5 Suppl E D):25. PubMed ID: 16641699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.
    Mease P; Genovese MC; Gladstein G; Kivitz AJ; Ritchlin C; Tak PP; Wollenhaupt J; Bahary O; Becker JC; Kelly S; Sigal L; Teng J; Gladman D
    Arthritis Rheum; 2011 Apr; 63(4):939-48. PubMed ID: 21128258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nurse's role in chemotherapy care].
    Rovelon P
    Soins; 2003 Mar; (673):37-9. PubMed ID: 12677922
    [No Abstract]   [Full Text] [Related]  

  • 18. H2-receptor antagonists.
    Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
    [No Abstract]   [Full Text] [Related]  

  • 19. Metoclopramide.
    Nurs Times; 2005 Mar 22-28; 101(12):37. PubMed ID: 15822709
    [No Abstract]   [Full Text] [Related]  

  • 20. Giving intravenous immunoglobulin.
    Scherf R; White-Reid K
    RN; 2008 Jan; 71(1):29-34; quiz 35. PubMed ID: 18271361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.